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Research Gold Medal Presentations winner
Simvastin reduces inflammation and
improves clinical outcomes in ALI: results
of the HARP study
T Craig, Royal Victoria Hospital, Belfast, Northern Ireland
Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS)
account for 19% of ventilated patients in Irish ICUs1 in keeping with
international data. There is no effective pharmacological treatment. There is
increasing evidence that statins may be useful in sepsis.2 In addition, statins
may also be a potential therapy in ALI as they modify many of the important
underlying processes.3 In an observational epidemiological study, ALI
patients pre-treated with statins had a 73% lower relative risk of death (OR
0.27, 95% CI 0.06-1.21 p=0.09). We have shown that statins lower
bronchoalveolar lavage (BAL) neutrophils in a healthy volunteer
lipopolysaccharide model of ALI, in part by increasing neutrophil 
apoptosis. Statins also reduce tumour necrosis factor-α (TNF-α),
matrixmetalloproteases -7,-8 and -9 in BAL fluid and lower plasma CRP.4
Extravascular lung water (EVLW) as a predictor of mortality 
ALI/ARDS, characterised by non-cardiogenic pulmonary oedema can be
assessed by measurement of EVLW. Traditionally EVLW has been indexed
to actual body weight (EVLWa). As lung size is dependent on height rather
than weight, we hypothesised indexing to predicted body weight (EVLWp)
may be a better predictor of mortality in all aetiologies of ALI/ARDS. 
We recorded demographics, severity of illness scores and
EVLWa/EVLWp by thermodilution (Pulse Contour Continuous Cardiac
Output system, PiCCO, Pulsion Medical, Münich, Germany). Using single
regressor logistic regression, six variables were significantly related to
mortality: APACHE II, PaO2, PaO2/FiO2 ratio, oxygenation index (OI),
EVLWa and EVLWp. In multiple logistic regression analysis, EVLWp but
not EVLWa was a predictor of mortality with an OR of 4.3 (95% CI 
1.5-12.9) per SD. A baseline EVLWp value of 16 mL/kg predicted ICU
mortality with a sensitivity of 0.75 (CI 0.47-0.91) and specificity of 0.78 
(CI 0.61-0.89). This study5 showed that early measurement of EVLWp is a
better predictor than EVLWa to identify patients at risk for death in
ALI/ARDS and may be a useful surrogate endpoint in clinical trials in ALI.
Results of the HARP study — a randomised double blind phase II
trial of simvastatin in acute lung injury
Patients admitted to the regional intensive care unit, Belfast were screened
for ALI according to consensus guidelines. Demographic information,
severity of illness scores including APACHE II, SAPS II, lung injury scores
(LIS) and GOCA scores were recorded.
Patients were randomised to 80 mg simvastatin or placebo for up to 14
days. EVLW, PaO2:FiO2 ratio, OI, plateau pressure and sequential organ
failure assessment (SOFA) score were recorded daily. Pulmonary
inflammation was assessed by BAL cytokines and systemic inflammation by
plasma CRP and cytokines. Safety data including CK, transaminases, need
for renal replacement therapy (RRT), adverse events and outcome data was
collected. Data were analysed by unpaired t tests or Mann Whitney U tests.
A χ2 or Fischer’s exact test was used to compare proportions.
Sixty patients were recruited. At day 7 there was no difference in EVLW
or other clinical outcomes. However by day 14, the simvastatin treated
group had improvements in oxygenation, respiratory mechanics and overall
non-pulmonary organ dysfunction (Figure 1) with improvement in the
cardiovascular (p=0.0001), renal (0.003), and coagulation (p=0.04) SOFA
components. At day 14, none of the simvastatin group required
vasopressors or inotropes (0% vs 33%; p=0.05). There was a trend to a
reduction in RRT in the statin group at day 14 (p=0.09). ICU mortality was
30% in both groups. Simvastatin was well tolerated with no increase in
adverse events.
Figure 1. Treatment with simvastatin 80mg improved pulmonary dysfunction,
as measured by oxygenation index (OI) (a), respiratory system compliance (Crs)
(b) and lung injury score (LIS) (c) and non-pulmonary organ dysfunction, as
measured by the Sequential Organ Failure Assessment (SOFA) score (d) at day
14 compared to day 0. Data are mean (SD) or median (IQR) as appropriate. 
By day 3 simvastatin decreased BAL IL-8 by 2.5 fold (p=0.04), and IL-6
by 2.9 fold although this was not significant (p=0.07). Plasma CRP
decreased in both groups at day 7 but was significantly reduced by day 14
in the statin group only (206.4 ±81.2 vs 77.6 ±72; p=0.0003). Simvastatin
had no effect on plasma cytokines.
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Translational and ongoing work 
Investigations are currently ongoing to attempt to elucidate the potential
mechanisms of statins in ALI. Based on data that MMP 9 may have a
beneficial effect on epithelial repair,6 we measured NGAL (neutrophil
gelatinase associated lipocalin), a complex of lipocalin and MMP-9 in
BAL fluid and plasma in ALI. Simvastatin had no effect on NGAL levels.
Patients whose BAL NGAL increased over the first 72 hours had
significantly lower EVLWp at day 3 than those whose BAL NGAL fell
(12.7+/-1.4 vs 18.9+/-2.6 mL/kg, p<0.05, n=24). All patients who
increased BAL NGAL concentration over the 72 hour period survived.
Day 3 BAL NGAL was >3 fold higher in ICU survivors compared with
non-survivors. In contrast, ICU survivors had a non-statistically
significant decrease in plasma NGAL at day 3 compared with non-
survivors (p=0.13). This suggests that an increase in NGAL in the
pulmonary but not systemic compartment is associated with improved
survival and clearance of EVLW. 
We have found for the first time that simvastatin 80mg once daily is safe
and is associated with improvement in pulmonary and non-pulmonary
organ dysfunction in ALI. The reduction in inflammatory mediators
indicates a potential mechanism for these effects. Phase III trials are
warranted to further assess the impact of statins in ALI.
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Endothelial dysfunction in critical illness
M Duffy, Ulster Hospital, Belfast, Northern Ireland
The endothelium has a key role in the maintenance of vascular
homeostasis.1 It actively regulates vascular tone, platelet aggregation,
coagulation, fibrinolysis and leucocyte activation.2 Endothelial function is
impaired in critical illness and may be important in the pathophysiology of
multiple organ failure. 
In vivo assessment of endothelial function in critical illness is difficult to
perform at the bedside. Estimates may be obtained indirectly by measuring
plasma levels of endothelium-derived regulatory proteins and
microalbuminuria. Microalbuminuria has been shown to be predictive of
outcome in a wide variety of acute conditions including trauma, surgery,
ischaemia-reperfusion injury, acute pancreatitis and meningitis. In a recent
prospective observational study, microalbuminuria measured within 15
minutes of admission to intensive care was as good a predictor of 
outcome as other validated severity of illness scores such as APACHE II 
and SAPS II.3
Pulse wave analysis (PWA) is a relatively new technique which uses a
validated transfer function to derive the central aortic waveform from the
peripheral pulse pressure wave.7 The central aortic pressure wave differs in
morphology from the peripheral pressure wave in that there are two
systolic peaks. The first systolic peak is due to ventricular systole and the
second is due to wave reflection. The difference in amplitude between the
first and second peaks, expressed as a percentage of the pulse pressure, is
known as the augmentation index (AIx). The AIx falls in response to
systemic vasodilatation. PWA combined with provocative pharmacological
testing has been validated as a simple, repeatable, non-invasive means of
assessing endothelial function in patients with cardiovascular disease. Its
use within the critical care setting has never previously been described.
Salbutamol is an endothelium-dependent vasodilator. Glyceryl trinitrate
(GTN) causes vasodilatation independently of the endothelium. The
change in AIx in response to salbutamol and GTN can be used to 
define endothelium-dependent vasodilatation (EDV) and endothelium-
independent vasodilatation (EIDV) respectively. The endothelial function
index (EFI) is the ratio of EDV to EIDV. EFI is therefore a surrogate marker
of systemic endothelial function.9
To explore the role of endothelial function in critical illness two clinical
studies were performed. The first, the Function of the Endothelium in
Critical Care (FECC) Trial was a prospective observational study in an
adult intensive care unit (ICU). Our hypothesis was that the EFI could be
used as a predictor of ICU mortality. The other was a prospective double-
blind randomised placebo-controlled clinical trial where PWA was utilised
to assess the ability of ascorbic acid to protect endothelial function post
ischaemia-reperfusion injury. 
Open abdominal aortic aneurysm (AAA) repair is associated with the
systemic inflammatory response syndrome (SIRS), mediated in part by an
increase in oxidative stress. Ischaemia-reperfusion injury induced by aortic
clamping is associated with both an increase in oxidative stress and a
decrease in antioxidant activity. Pro-inflammatory cytokines and markers of
endothelial damage are increased by this insult.10 Our hypothesis was that
the intraoperative administration of intravenous ascorbic acid, an powerful
water soluble antioxidant, may attenuate endothelial injury and this was
investigated in the Ascorbic Acid in AAA (AAAAA) trial. 
Methods
FECC
Adults admitted to the regional intensive care unit (RICU) in the Royal
Victoria Hospital, Belfast were considered for inclusion. All consecutive
patients were approached. PWA was performed within 24 hours of
admission. Baseline demographic and physiological indices were recorded.
Severity of illness scores (APACHE II, SAPS II, SOFA) were calculated. ACR
was measured as were serum adhesion molecules. Follow-up was to
hospital discharge.
AAAAA
Consecutive patients admitted to the regional vascular unit in the Royal
Victoria Hospital, Belfast for elective open AAA repair were considered for
recruitment. Ascorbic acid 2 g or placebo was given intravenously prior to
application of the aortic clamp. Demographic and physiological indices
were noted. Clamp time was recorded. Blood and urine samples were taken
prior to and 4 hours after aortic clamping. Concomitantly, bedside analysis
of endothelial function was performed using PWA. Serum adhesion
molecules, plasma inflammatory cytokines and urinary ACR were
measured. Exhaled breath condensate (EBC) was collected before and after
aortic clamping and pH measured as a marker of pulmonary inflammation.
The PaO2:FiO2 ratio (P:F Ratio) was calculated as a measure of pulmonary
function. Data are presented as median (inter-quartile range).
Results
FECC
Ninety-nine participants were studied, there were 83 survivors and 16 non-
survivors. No differences were found in demographics between survivors
and non-survivors. The severity of illness scores, ACR and leucocyte count
were significantly higher in non-survivors. A multiple logistic regression
demonstrated that the EFI was the most accurate predictor of ICU
mortality, and had the highest area under the ROC curve (Figure 1).
Figure 1.
Predictive test ROC AUC 95% CI p-value
EFI 0.990 0-1 <0.0001
APACHE II 0.670 0.514-0.826 0.032
SAPS II 0.722 0.595-0.849 0.005
SOFA 0.707 0.560-0.853 0.009
Urinary ACR 0.694 0.579-0.809 0.017
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AAAAA
Thirty-one patients were studied. There were no differences in
demographics or clamp times between groups. EBC pH fell after aortic
clamping in both placebo and ascorbate groups, but with no difference
between groups (Figure 2a). The P:F Ratio fell by 14.3 (2.0,38.6) kPa in
the placebo group (p=0.008) and by 19.9 (3.6, 57.7) kPa in the ascorbate
group (p=0.003), there was no significant difference between groups
(p=0.48). There were no differences in levels of soluble adhesion molecules
between groups. The ACR was significantly increased after aortic clamping
with a rise of 9.6 (2.2,29.8) mg.mmol-1 in the placebo group (p=0.001) and
4.75 (0.9, 20.0) mg.mmol-1 in those who received ascorbic acid (p=0.001).
Again there was no significant difference between groups (p=0.1).
EFI was improved after open AAA repair in the ascorbate group,
whereas there was no significant change in the placebo group (Figure 2b).
Regarding inflammatory cytokines, the post-operative level of IL-6 was
lower in those who received ascorbic acid (Figure 2c). 
Figure 2. (a) EBC pH falls after aortic clamping. (b) EFI improves following
open AAA repair after ascorbic acid administration. (c) IL-6 lower after open
AAA repair in those who received ascorbic acid.
Conclusion
The EFI is a good independent predictor of mortality in intensive care. We
have shown it to be superior to other validated severity of illness scores
including APACHE II and SAPS II. In vivo bedside assessment of systemic
endothelial function may enable the targeting of new endothelial therapies
in critical illness.
Our AAAAA study has suggested that high-dose ascorbic acid may 
be beneficial to the endothelium during ischaemia-reperfusion injury. 
This important novel finding warrants further investigation to assess its
clinical significance.
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Regional pathophysiology, tissue fate and
outcome in traumatic brain injury; insights
from diffusion tensor imaging
V Newcombe, University Division of Anaesthesia, Cambridge, UK
Introduction
Conventional imaging techniques are poor at demonstrating traumatic
brain injury (TBI), particularly traumatic axonal injury (TAI), and there is
limited information regarding its incidence, extent, temporal profile and
possible resolution. MRI with diffusion tensor imaging (DTI) characterises
the diffusion of water molecules in tissue environments, which is
influenced by the microstructural organisation of tissues and their
constituent cells, and can provide unique insights into pathophysiology,
particularly in white matter (WM). The diffusion tensor can be used to
represent the magnitude of water diffusion (quantified as the apparent
diffusion coefficient, ADC), whether such diffusion is directionally non-
uniform (fractional anisotropy, FA), and the orientation of that direction
(eigenvectors/eigenvalues). 
Previous DTI studies mainly assessed WM injury in TBI, and showed
consistent reductions in fractional anisotropy (FA) in classical areas affected
by TAI, even when conventional MRI showed no lesion.1-7 Yet the evolution
of these changes and their correlation with patient outcome is still poorly
understood. The major aim of this project was to use diffusion tensor
imaging (DTI) to characterise TBI in both the acute and chronic phases,
and correlate findings with neurocognitive and functional outcome. 
Lesion characterisation and evolution
Six patients (median Glasgow Coma Score (GCS) 6 (range 3 to 13)) with
contusions were imaged twice while in intensive care at a median of 28
(range 20 to 44) and 182 (range 68 to 283) hours post injury (Figure 1).8,9
Within the first 48 hours, all lesions showed three regions; a core, an area
of raised ADC around the core, and a thin rim of hypointensity. While
some lesions showed these regions more clearly than others, this pattern
was universal. Over time, the ADC in the core increased, probably
reflecting haematoma evolution. Early ADC reduction in the hypointense
rim may represent cytotoxic oedema, perhaps due to critical ischaemia,
resulting from microvascular changes.10 This area evolves into a vasogenic
picture over time, and is subsumed by the area of raised ADC. These
imaging appearances may characterise the traumatic penumbra, where
physiology is acutely deranged, but clinical interventions may enhance
tissue survival.11
Understanding the microstructural basis of subtle 
white matter injury
DTI data were analysed in normal appearing whole brain WM (WBWM) in
33 patients with moderate to severe TBI (median GCS 6, range 3 to 11) 
Figure 1. Heterogeneity in the cerebral pathophysiology following head injury.12
The top panel shows FLAIR, positron emission tomography (PET) regional
cerebral blood flow (rCBF), and ADC maps obtained at 14 hours post TBI. The
lower panel shows a detail of these images, and a follow up image at 158
hours (6.5 days) post TBI. The shearing injury in the left basal ganglia shows
regions of both increased and decreased rCBF. There is a reduction in rCBF
around the right frontal contusion, which is peripheral to the pericontusional
cuff of vasogenic oedema, and associated with a reduction in ADC,
characteristic of cytotoxic oedema. The lower images (FLAIR, ADC map and
PET CBF at 14 hours, with FLAIR at 6.5 days) illustrate how the rim of
vasogenic oedema extends to include the rim of cytotoxic oedema seen at the
early time point. 
imaged at a median of 32 hours (range 7 to 132 hours) post injury. FA was
decreased and ADC increased compared to controls (p<0.001 and p=0.017,
respectively, Mann-Whitney U).13,14 These changes resulted predominantly
from selective increases in radial diffusivity (rather than decreases in axial
diffusivity). In contrast, a decrease in ADC was seen in the grey matter.15,16
The differences seen in the grey and white matter ROIs emphasise the need
to separate these structures when investigating pathological changes. These
data suggest that early pathology of TAI may be dominated by reversible
cytotoxic oedema, rather than traumatic axotomy.
Longitudinal imaging
Eight patients were imaged sequentially at five time points: within the 
first week, ~10 days, 4 to 8 weeks, 6 to 12 months, and over 12 months
post-injury (Figure 2). In the first week FA in WBWM was lower than
controls, this decreased progressively with the second acute scan and the
subacute scan. FA increased at the 6 month scan and increased further at
the >12 month scan, but remained lower than the initial scan 
(Freidman’s ANOVA, p=0.004 and <0.001 respectively). Although the initial
reductions in FA may arise from WM oedema, most oedema should have
resolved at the intermediate time point. Any ongoing FA reductions are
likely to reflect inflammation, demyelination, atrophy, and plasticity. 
Such serial imaging may provide a valuable readout of ongoing tissue injury
over time.
Relationship to clinical outcomes
Clinical outcome, defined by the Glasgow Outcome Score, was related to
the burden of white matter injury quantified by DTI late after TBI (Figure
2).17,18 This study is the first DTI study to address the entire spectrum of
survivors and provides a comprehensive context for DTI data
interpretation. Mean FA and eigenvalues, were obtained for supratentorial
white matter, the pons, midbrain and corpus callosum, in 64 patients at a
median of 11.8 months post TBI, and in 36 healthy volunteers. Decreasing
FA was related to poorer outcome (all p-values <0.001; corrected for
multiple comparisons [Jonckheere-Terpstra Test for trend]). FA changes
were accompanied by an increased radial, and to a lesser extent, axial
diffusivity. This analysis showed that clinical outcome correlates with the
burden of white matter injury. DTI abnormalities were also seen in the
patients with the best outcomes, and patients in whom conventional MR
was normal, suggesting that DTI can detect subtle injury missed by other
approaches. 
Figure 2. This image shows examples of FLAIR and “global” tractography
maps created using DTIQuery19 with representative examples from a control
and GOS categories 2 to 5 to illustrate qualitative changes in white matter
integrity over time. The FLAIR and acute scan was within the first week of
injury, the subacute at approximately 4 to 8 weeks and the chronic at six
months except for the VS patient whose third scan was at four months. It can
be clearly seen that the “paths” able to be traced are far less in the patients
than the controls despite similar appearing conventional structural imaging.
The “paths” also tended to decrease over time. All patients shown did not
have any contusions except for the VS patient who had bilateral frontal
contusions. These appearances were underpinned by the gradations of change
seen in the quantitative measures of DTI parameters. For ease of
visualisation, tracts with lengths less than 7.5cm are not shown. GR = good
recovery (GOS 5), MD = moderate disability (GOS 4), SD = severe disability
(GOS 3) and VS = vegetative state (GOS 2). 
Neuroanatomical substrates for late neurocognitive deficits
Neurocognitive dysfunction after traumatic brain injury (TBI) correlates
imperfectly with lesion distribution, and may result from subtle insults to
integrated neural systems, rather than overt lesions at focal injury sites. The
hypothesis that the burden of microstructural injury, as defined by DTI,
would correlate with neurocognitive performance was tested in two
contexts: a visual memory task (Paired Associates Learning; PAL),
involving cholinergic networks; and a decision making task (Cambridge
Gamble Task; CGT), subserved by dopaminergic networks.20 Structural
MRI and DTI were undertaken, at least 6 months post-injury, in 42 patients
(median admission GCS 6 (range 3 to 15), with traumatic axonal injury
and no significant focal lesions. Testing with the Cambridge
Neuropsychological Automated Test Battery (CANTAB) was performed on
the same day. Multi-component ROIs were manually created for each task,
based on prior knowledge of their neuroanatomical correlates. For both
tasks, ADC in key areas identified from previous data, correlated
significantly with task performance (p<0.05). Our data add to the evidence
that loss of microstructural integrity, as detected by DTI, is an important
determinant of function following TBI, and confirm the involvement of key
neurochemical networks in these complex neurocognitive tasks. 
Conclusions
The use of modern imaging tools such as DTI is challenging in the context
of acute TBI, and clinical and logistic realities meant that we could not
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recruit as many subjects that we wished to, or undertake imaging at tightly
defined time points post-TBI. Nevertheless, this includes the largest
collection of patient data of this detail available in the literature, and the
analyses presented here show how DTI may be used to more fully
characterise the disease processes post TBI in vivo. An improved in vivo
understanding of the pathology of traumatic brain injury (TBI), including
its distribution, extent and temporal profile, may enhance outcome
evaluation and help to provide a mechanistic basis for deficits that remain
unexplained by other approaches.
Statement of contributions and acknowledgements: The above
analyses were performed as part of my PhD supervised by Professor David
Menon and Dr Guy Williams and funded by a Gates Cambridge
Scholarship and an Overseas Research Studentship. I was involved in the
experimental design, data collection, data analysis, construction of new
analytic tools, presentation of data and writing of the above manuscript.
The data from patients in the vegetative state used in the analysis described
in Section 5 were kindly provided by Dr Martin Coleman. Patient transport
for scanning for these studies was undertaken by a cohort of Clinical
Research Fellows in our group, who used the imaging procedure to collect
data for distinct PhD/MD projects.
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Ventilator-associated pneumonia is
characterised by elevated neutrophil
proteases in the lung
A Conway Morris*, K Kefala*, C O’Kane†, DF McAuley†, TS Wilkinson*, K
Dhaliwal*, H Reid‡ , TS Walsh§, AJ Simpson*. *MRC Centre for
Inflammation Research, University of Edinburgh, Scotland, †Centre for
Infection and Immunity, Queen’s University, Belfast, Northern Ireland,
§Department of Critical Care, Royal Infirmary of Edinburgh, Scotland,
‡Penicuik Medical Practice, Penicuik, Midlothian, Scotland, UK
Ventilator-associated pneumonia (VAP) is a significant problem in intensive
care units, leading to increased morbidity, mortality and duration of stay.1
Excessive release of proteases has been implicated in the pathogenesis in a
variety of inflammatory lung diseases. We set out to quantify major
proteases (matrix metalloproteinases (MMPs) and the serine protease
neutrophil elastase (NE)) in VAP.
Fifty-five patients with clinically suspected VAP (chest X-ray
infiltrates, plus two or more of elevated white cells, temperature above
38°C and muco-purulent sputum)1 underwent standardised
bronchoscopy and bronchoalveolar lavage (BAL). VAP was defined as
growth of organisms above 104 colony forming units/mL. A group of 18
age- and sex-matched volunteers acted as a reference group and also
underwent BAL. Samples were assayed for matrix metalloproteases
(MMPs) 1,2,3,8 and 9 by Luminex assay. Tissue inhibitor of MMP
(TIMP)1 and 2, neutrophil elastase (NE), and elastase inhibitors 
(α-1 antitrypsin, elafin and secretory leukocyte protease inhibitor (SLPI))
were assayed by sandwich ELISA.
Eleven (20%) patients had confirmed VAP, 44 (80%) fell into the ‘non-
VAP’ group. Levels of the proteases assayed are shown in the Table, the
neutrophil-derived proteases (MMP 8, 9 and NE) being significantly
elevated in patients with VAP compared to those without VAP. Correcting
for total neutrophil number did not alter this relationship.
This work suggests that microbiologically confirmed VAP is
characterised by activation of neutrophils, resulting in the release of
Protease/inhibitor VAP Non-VAP P value Matched
(median and inter- (Mann- volunteer
quartile range) Whitney reference group
U test) (median and 
inter-quartile 
range)
MMP1 (pg/mL) 142.0 116.0 0.69 All below limit
(46.7-310.1) (35.6-256.8) of detection
MMP2 (ng/mL) 3.9 (3.3-8.6) 4.7 (1.4-14.7) 0.9 0.9 (0.4-19.2)
MMP3 (pg/mL) 408.8 115.8 0.07 77.5
(86.5-866.2) (35.46–402.8) (50.7- 80.0)
MMP8  (ng/mL) 184.4 5.2 0.002 2.4 
(18.3-513.4) (1.2-56.5) (1.2-20.0)
MMP9 (ng/mL) 310.2 10.5 0.003 3 
(21.8-746.4) (0.2-90.0) (0.94-59.8)
TIMP-1 (ng/mL) 58.0 29.9 0.3 4.3 (2.6-40.9)
(20.6-160.0) (13.2-97.7)
TIMP-2 (pg/mL) 5.7 (2.4-10.5) 2.9 (1.1-6.0) 0.15 1.4 (0.9-4.9)
Neutrophil elastase 2.7 (0.7-13.3) 0.3 (0.1-0.6) 0.0006 0 (0-0.4)
(μg/mL)
α-1 antitrypsin 3.9 (1.1-20.6) 5.3 (1.7-16.3) 0.66 1.3  (0.7-7.4)
(mg/mL)
Elafin (ng/mL) 5.0 (3.4-19.0) 5.2 (1.1-11.9) 0.28 2.8  (1.1-11.5)
SLPI (ng/mL) 6.0 (4.0-70.8) 7.3 (1.0-38.0) 0.2 4.9 (0-38.0)
Neutrophils (105/mL) 2.8 (0.6-21.0) 3.2 (0.3-12.0) 0.6 0 (0-0.03)
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proteolytic enzymes which may damage pulmonary tissue and 
contribute to respiratory failure. The difference in proteases is not
mirrored by their inhibitors, suggesting that protease-inhibitor
imbalances may play a role in the pathogenesis of VAP. Previous work by
our group has shown alveolar neutrophils in VAP to have defective anti-
bacterial function.2 The emerging picture of VAP is of a ‘worst case
scenario’, with neutrophils unable to efficiently clear bacteria but
remaining toxic to host tissues.
Funding: This work was funded by the Sir Jules Thorn Charitable
Trust.
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Clinical Practice Free Paper Presentations winner
Midazolam and brain stem testing
C Buss, J Brander, S Brown, D Gardiner, Nottingham University
Hospitals Trust, Queens Medical Centre, Derby Road, Nottingham, UK
The new Academy of Medical Royal Colleges, A Code of Practice for the
Diagnosis and Confirmation of Death states, “If midazolam levels are
available brain-stem testing should not be undertaken if the level is
>10µg/L.”1 Since the release of the code of practice our institution has had
three patients where concern over potential midazolam levels have
prohibited or deterred the clinician from brain stem testing.
The first case received 105 hours of sedation with midazolam
(1291 mg), morphine (1285 mg) and propofol 1(6240 mg). Twenty-one
hours after sedation was ceased the midazolam level was 5500 µg/L. 
The second case received 27.5 hours of sedation with midazolam
(496mg) and morphine (266 mg). Twenty and a half hours after sedation
was ceased the midazolam level was 218 µg/L. A second level three and a
half hours later was 140 µg/L giving a elimination t1/2 of 4.4 hours,
significantly higher than that suggested for the context sensitive half time
for midazolam (75 minutes)2 but within the range of other reports.3
The third case received 64 hours of sedation with midazolam (274 mg),
morphine (247 mg) and propofol (400 mg). Twenty-two hours after
sedation was ceased a non-urgent midazolam level was requested on the
assumption the level would be high. The level was <10 µg/L. This patient
had a six hour ‘sedation hold’ of midazolam during an operative procedure
where remifentanil and volatile anaesthesia was used.
To investigate the potential impact of the new code of practice on our
institution’s ability to carry out brain stem testing, a review was undertaken
of brain stem tested patients during the two years prior to Case 1.
Twenty four patients were reviewed and of these 21 had received
sedation on ICU. The median time for brain stem testing from cessation of
sedation was 16 hours. Ten patients received propofol without midazolam
or morphine. 
Of the remaining 11 patients, seven received midazolam (median dose
of 110 mg, median duration of sedation 26 hours and median time to brain
stem testing after sedation ceased of 24.5 hours). Of potential conflict with
the new Code of Practice one patient received a dose of midazolam similar
to Case 2 and was brain stem tested at 32 hours and another patient
received a midazolam dose of 3150mg and was tested at 33 hours.
The Code of Practice will impact on brain stem testing. It raises many
issues regarding the pharmacokinetics of sedatives on ICU and neuro-
critical care sedation in general.
References
1. Academy of Medical Royal Colleges, A code of practice for the diagnosis and
confirmation of death. Academy of Medical Royal Colleges 2008 (page 14)
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Research Poster Presentations winner
Early brain tissue oxygenation is related to
selective neuronal loss following clinical
head injury
V Newcombe*†, I Timofeev‡, C Williams*, D Chatfield*†, P Hutchinson†‡, 
J Coles*†, J Pickard†‡, G Williams†, A Gupta*, D Menon*†. *University
Division of Anaesthesia, †Wolfson Brain Imaging Centre, Department of
Clinical Neurosciences,  ‡Academic Neurosurgery Unit, University of
Cambridge, UK
We have previously used 11C-flumazenil positron emission tomography  to
show that selective neuronal loss in the thalamus is pervasive after
traumatic brain injury (TBI) and correlates with functional outcome.1
The mechanisms responsible are unclear, but may involved global
hypoxia/ischaemia as well as retrograde degeneration. We hypothesised
that early brain tissue oxygenation would correlate with late magnetic
resonance imaging (MRI) with diffusion tensor imaging (DTI)
abnormalities  in the thalamus, and therefore, help provide an explanation
for late neuronal loss. 
Nine patients underwent brain tissue oximetry (PbO2) following acute
TBI, using a Licox PbO2 probe, sited in structurally normal frontal white
matter. Mean PbO2 was calculated for the duration of their ICU stay. At a
median of 11.6 months (range 237 to 702 days) they underwent MRI with
DTI. Apparent diffusion coefficient ADC (maps) were created, ADC
calculated in regions of interest in the frontal lobes, splenium of the
corpus callosum and thalami, and correlated with mean PbO2 using
Spearman’s Rho. Research ethics approval and assent from next-of-kin
were obtained.  
Mean PbO2 was inversely related to ADC in both frontal lobes (r=-0.73
& -0.72;  p=0.025 & 0.031), and with the ADC in the thalamus bilaterally
(r=-0.87 & -0.80; p=0.002 & p=0.010; Figure). In contrast, no correlation
was seen between mean PbO2 and ADC in the splenium of the corpus
callosum, a common site of traumatic axonal injury (TAI;  p=0.265). 
The inverse correlation of mean PbO2 with ADCs in the monitored
brain region is unsurprising, but the correlations observed with
contralateral regions and deep grey matter suggest that the burden of tissue
hypoxia has a significant impact on secondary neuronal loss across the
brain.  In contrast, the lack of correlation with ADC changes in an area at
risk of TAI suggests that mean PbO2 levels may be less useful in monitoring
the impact of secondary insults on the maturation of TAI. The correlations
with measures of thalamic microstructural injury are particularly
significant, since they establish a clear link between acute physiology, tissue
fate in key brain regions, and clinical outcome. 
Acknowledgments: MRC, NIHR, Royal College of Anaesthetists, Health
Foundation, Academy of Medical Sciences, Gates Foundation, Cambridge.
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Research Free Papers Presentations runners-up
A randomised controlled trial of the effects
of three haemodynamic therapies on
microvascular flow, tissue oxygenation and
inflammatory markers after major
abdominal surgery
S Jhanji, A Vivian-Smith, S Lucena-Amaro, D Watson, CJ Hinds, RM Pearse,
William Harvey Research Institute, Barts and The London School of
Medicine and Dentistry, London, UK
Perioperative Goal-Directed Haemodynamic Therapy (GDHT) appears to
improve outcome.1 Importantly, the biological mechanisms underlying this
therapy have not been investigated.2 The objective of this study was to
assess the effects of three haemodynamic regimens on tissue microvascular
flow and oxygenation in patients after major abdominal surgery.
Approval from the local ethics committee and the competent authority
were granted. Patients were stratified according to surgical specialty.
Patients were then randomised to receive one of three haemodynamic
protocols for eight hours immediately following major abdominal surgery.
The central venous pressure (CVP) group received intravenous (IV) colloid
boluses to achieve a sustained rise in CVP. The stroke volume (SV) group
received IV colloid boluses to achieve a sustained rise in SV. In the SV plus
dopexamine group, patients received IV colloid boluses to achieve a
sustained rise in SV plus a fixed rate infusion of dopexamine
(0.5 µg/kg/min). Data collected every two hours included mean arterial
pressure (MAP), oxygen delivery index (DO2I) (lithium dilution and pulse
power analysis), central venous oxygen saturations (ScvO2), sublingual
microvascular flow videos (sidestream darkfield imaging), cutaneous
microvascular flow (laser Doppler) and cutaneous tissue PtO2 (Clark
electrode). Serum Il-1ß, Il-6, Il-β, TNF-α and ICAM-1 were also measured.
Data are presented as mean (SD) or absolute values (%). 
One hundred and thirty-five patients were recruited in 15 months.
Following surgery, SV-guided fluid therapy with dopexamine was associated
with a significant increase in DO2I, sublingual microvascular flow, the
cutaneous hyperaemic response and tissue PtO2 during the intervention
period (Figure 1). There were no differences in serum inflammatory
markers, post-operative complications, hospital stay or mortality.
GDHT with dopexamine results in an improvement in global
haemodynamics, tissue microvascular flow and oxygenation but no change
in systemic inflammatory markers.
Grant acknowledgement: ESICM/ECCRN Spacelabs Intelligent
Monitoring Award 2006. RMP is an NIHR clinician scientist. SJ, CJH and
RMP are named inventors on a patent application relating to dopexamine.
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Evolution of gene expression signatures in
septic shock due to community-acquired
pneumonia
J Radhakrishnan*, E Svoren†, P Ellis‡, C Langford‡, P Hutton§, C Garrard§,
CJ Hinds* JC Knight# and the GAinS Investigators. *Wellcome Trust
Centre for Human Genetics, University of Oxford, Oxford, UK, †Queen
Mary University of London, Barts and The London School of Medicine and
Dentistry, UK, ‡Wellcome Trust Sanger Institute, Cambridge, UK,
§Intensive Care Unit, John Radcliffe Hospital, Oxford, UK
Severe sepsis and septic shock involve a dynamic process of gene
reprogramming. Emerging evidence suggests that changes in gene
expression influence clinical outcome, but our knowledge of the genome
wide temporal evolution of these changes remains limited1,2 and studies to
date have typically involved non-homogeneous sepsis cohorts.
To investigate temporal changes in global gene expression profiles and
identify predictors of mortality, we studied patterns of gene expression in
patients admitted to intensive care units (ICU) with septic shock due to
community acquired pneumonia (CAP). Following ethics committee
approval and informed consent, serial samples of peripheral blood
leukocytes were collected on days 1, 3 and 5 of ICU admission from 28
patients (15 survivors, 13 non-survivors). To provide a baseline for
comparison, control samples were also obtained from 15 cardiac surgery
patients prior to induction of anaesthesia. Leukocytes were collected using
the LeukoLOCK system (Ambion). Total RNA was isolated and genome-
wide gene expression profiles obtained using the Illumina Human WG-6 v3
Beadarray platform that interrogates more than 48,000 unique transcripts.
Gene expression data was analysed by fitting a linear model using a
Bayesian algorithm. Samples from CAP survivors (S) and non-survivors
(NS) were compared independently to the baseline control samples for each
of the three time points. Between 600 and 1300 genes were at least 1.5 fold
differentially expressed with an adjusted p value less than 0.01 for each
time point comparison. Pathway analysis was performed with the Gene Set
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Enrichment Algorithm using pathways derived from Gene Ontology
database, KEGG and published literature. Fewer pathways were enriched in
NS as compared to S. A mixture of immune related signalling, transport,
and biosynthetic pathways were significantly enriched, with different
patterns of enrichment observed at each of the time points.
Models were also fitted to compare S and NS at different time points.
Transcript levels of some of the classical protein markers of sepsis (TNF,
IL6 and ILβ‚) did not differ between S and NS. In contrast NS showed
persistent up-regulation of key pattern recognition receptor genes (eg
TLR2, TLR4, TLR6), suggesting on-going activation of the innate immune
signalling pathways.
By studying sequential changes in genome wide gene expression profiles
we have characterised evolving patterns of gene expression that
differentiate S from NS of septic shock due to CAP. It is hoped that novel
insights derived from such studies may lead to the development of genomic
biomarkers for prognosis or individually targeted interventions, as well as
suggesting new therapeutic approaches.
This study was supported by the Wellcome Trust and a Young
Investigator Award from the Intensive Care Society.
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Research Poster Presentations
Plasma C5a, IL-6 and IL-10 are elevated
prior to nosocomial infection in critically ill
patients: a preliminary report
A Conway Morris*, J Antonelli†, C McCulloch† RO Jones*, I Laurenson§,
DG Swann‡, A Hay‡, TS Walsh‡, AJ Simpson*. *MRC Centre for
Inflammation Research, University of Edinburgh, Scotland, UK, †Clinical
Research Facility, Royal Infirmary of Edinburgh, Scotland, UK,
‡Department of Critical Care, Royal Infirmary of Edinburgh, Scotland, UK,
§Department of Medical Microbiology, Royal Infirmary of Edinburgh,
Scotland, UK
Nosocomial infections are a significant problem within the intensive care
unit. The frequency of these is thought to reflect dysfunction of the
immune system, however debate continues as to the mediating factors and
the temporal pattern of immune dysfunction. We have previously
demonstrated that C5a, a pro-inflammatory complement fragment, can
drive neutrophil dysfunction.1 This work is a preliminary report from a
project examining the relationship between immune function and the
acquisition of nosocomial infection. 
Critically ill patients (patients requiring support of ≥1 organ systems for
≥48 hours) admitted to a single intensive care unit were recruited within 
48 hours of admission. Serial samples of blood were taken and analysed 
for plasma immuno-tropic molecules. Infection was determined by 
pre-defined criteria, in cases of dubiety an expert consensus panel was
asked to adjudicate. Patient data was censored from 48 hours before
nosocomial infection occurred to reduce the risk of infection itself causing
the effect seen.
Twenty-six patients have been recruited to date, 8 (31%) have
developed confirmed or probable infection. Patients with IL-6 and C5a
above median at admission, and those with levels of IL-6 or IL-10 elevated
above median during their ICU stay were at significantly increased risk of
infection (see Table). Other measured cytokines (IL-8, IL-1, TNF-α and IL-
12) showed no relationship with nosocomial infection. There was no
difference in severity of illness (APACHE II score) or organ failures 
(SOFA score) at admission between those who developed infection and
those who did not. There was no relationship between these scores and the
inflammatory mediators measured.
This work suggests that hyper-inflammation is associated with, and
precedes, the acquisition of nosocomial infection. This may be due to pro-
inflammatory molecules driving dysfunction, or indirectly by driving an
anti-inflammatory response. However further work and patient recruitment
is required to determin whether these molecules are independent predictors
or simply reflecting other processes. 
Funding: This work is funded by the Chief Scientist Office.
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neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med 2009;180:19-28.
C5a drives phagocytic dysfunction via a
PI3K delta-dependent inhibition of actin
polymerisation
A Conway Morris*, AG Rossi*, TS Walsh†, AJ Simpson*. *MRC Centre for
Inflammation Research, University of Edinburgh, Scotland, UK,
†Department of Critical Care, Royal Infirmary of Edinburgh, Scotland, UK
The complement split-product and anaphylotoxin, C5a, causes defects in
neutrophil phagocytosis in animals1 and humans2 with sepsis. Although
dependency on the phosphoinositol 3-kinase (PI3K) pathway has been
identified,2 the mechanism of dysfunction is poorly understood.
An in-vitro model of C5a-mediated neutrophil dysfunction was created
by treating healthy human donor neutrophils with C5a at concentrations
found in sepsis (100nM). Phagocytosis was assessed using serum-opsonised
zymosan particles. The involvement of the PI3K pathway was investigated
using pan-PI3K inhibitors wortmannin and LY292004. Iso-form specific
inhibitors IC87114 and AS605240, which inhibit the δ and γ iso-form
respectively, were used to further define the pathways involved. Actin poly-
merisation was assessed using a fluorescent probe for f-actin (phalloidin).
The ability of granulocyte-macrophage colony stimulating factor (GM-CSF)
to ‘rescue’ actin polymerisation was investigated. Phagocytosis by
neutrophils from critically ill patients was investigated, actin polymerisation
determined and the effects of ex-vivo GM-CSF evaluated.
C5a inhibited phagocytosis of zymosan; an effect prevented by 
pre-treatment with pan-PI3K inhibitors. Pre-treatment with the PI3Kγ
inhibitor failed to prevent the effect of C5a. In contrast, pre-treatment with
the PI3Kδ inhibitor was effective. C5a treated neutrophils failed to
polymerise actin in response to zymosan and this effect could be prevented
by treatment with a PI3K inhibitor (see figure). This defect was reversed 
by treatment with GM-CSF. PI3K inhibitors applied after treatment with
C5a were unable to rescue phagocytosis. GM-CSF, applied ex-vivo,
improved phagocytosis in neutrophils from patients with critical 
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illness. In these patients phagocytosis correlated with the change in
polymerised actin in neutrophils following exposure to a phagocytic target
(r=0.62 p=0.003).
These data suggests that C5a activates PI3Kδ which in turn inhibits
actin polymerisation, so preventing phagocytosis. GM-CSF is able to
reverse the inhibition of actin polymerisation. This work increases
understanding of the pathways underpinning phagocytic defects in
critically ill patients and provides further insight into how GM-CSF is able
to rescue neutrophil function.
Funding: This work was funded by grants from the Chief Scientist
Office and Sir Jules Thorn charitable trust.
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Ischaemic ECG changes in septic shock: 
a comparison of vasopressin and
noradrenaline
AC Gordon*, S Mehta†, S Lapinsky†, G Newton†, D Ayers‡, J Singer‡, KR
Walley‡, JA Russell‡ for the VASST Investigators.
*Critical Care, Charing Cross Hospital, Imperial College London, UK.
†University of Toronto, Canada, ‡University of British Columbia, Canada
There is concern that vasopressin may increase myocardial ischaemia when
used in the treatment of septic shock. We therefore compared rates of
ischaemic ECG changes in vasopressin and noradrenaline treated patients
who had septic shock enrolled in the VASST study.1
Patients who had septic shock were randomised to receive a blinded
infusion of low-dose vasopressin or noradrenaline in addition to open-label
vasopressors. The ECG substudy was carried out in eight centres who
participated in the VASST study. Patients who had a 12-lead ECG at
baseline and at least one further ECG within four days were included.
ECGs were analysed independently and in duplicate by a cardiologist and
intensivist, blinded to treatment allocation. Definitions of abnormalities and
a checklist were drawn up before analysis. Ischaemia was defined as present
if identified in two analyses. Categorical variables were analysed using the
chi-square test and continuous variables using the T-test. Multivariate
regression analysis was run to adjust for age, APACHE II score, sex,
ischaemic heart disease and dose of noradrenaline at baseline.
One hundred and three patients and 366 ECGs were included. The
mean age was 62.8 ± 16.8 years, mean APACHE II score 28.5 ± 7.5, 76
(73.8%) were male, and 53 patients were treated with vasopressin and 50
patients with noradrenaline. Eighteen patients (17.5%) developed new
ischaemic changes. Patients who developed ischaemia were older 
70.7 v 61.2 years (p=0.03), had higher APACHE II scores 33.8 v 27.3
(p=0.001) and had a trend to a higher 28-day mortality rate 58.8 v 36.5%
(p=0.1). There was no difference in rates of ischaemic changes in the
vasopressin group (18.9%) compared to the noradrenaline group (16.0%,
p=0.8). On multivariate analysis the vasopressin group had an odds ratio
for ischaemic changes of 1.49 (95%CI 0.48 - 4.60).
Ischaemic ECG changes were common (17.5%) but there was no
difference in occurrence between vasopressin and noradrenaline treated
patients in this substudy from VASST.
Funding: Canadian Institutes of Health Research and UK NIHR BRC
funding scheme.
Reference
1. Russell JA, Walley KR, Singer J, Gordon AC et al. Vasopressin versus norepinephrine
infusion in patients with septic shock. New Engl J Med 2008;358:877-87.
Is non-invasive cerebral saturation a good
indicator of invasive oxygen extraction?
MS Thorniley, Z Bashir, C Slinger, S Haynes, A Mortimer, CN McCollum.
Department of Academic Surgery, University Hospital of South Manchester,
Manchester, UK
Major vascular surgery is frequently associated with blood loss and the
current clinical decision to transfuse red cells is mutifactorial. The
indicators to transfuse include haemoglobin concentration (Hb), blood
loss, cardiovascular parameters and mixed venous oxygen saturation. The
decision to transfuse should be to maintain adequate tissue oxygenation.
The physiological response to blood loss is to increase cardiac output to
maintain delivery. If the cardiac output cannot be improved the oxygen
extraction ratio will increase to maintain tissue oxygenation. Systemic
OERs can be a sensitive indication of changes in oxygen consumption/
delivery and it has been reported by Orlov et al1 that they can be used as a
more appropriate transfusion trigger. However, OER is invasive. Near
infrared spectroscopy measures cerebral haemoglobin oxygen saturation
(CsO2) and has been shown in previous work by our group to fall
significantly during aortic aneurysm surgery. The aim of this study was to
determine if the noninvasive measurements of CsO2 correlated with OER
measurements in patients undergoing elective abdominal aortic aneurysm
surgery (AAA). The target Hb for blood transfusion is 70-90 g/L2 and Hb in
this region is frequently associated with higher than normal Lac levels.
Furthermore, regression analysis was determined for all patients with a Hb
value <90g/L and a Lac level greater than the mean 2mM to determine the
relationship of CsO2 with OER in this critical region.
Cerebral and peripheral continuous NIRS (Somanetics INVOS
instrument) measurements were made in 66 patients undergoing AAA
surgery. Measurements were made from incision to closure. Hb
measurements were made from a central venous line. Statistical analysis
was determined using SPSS 15.0.
A significant moderate negative relationship was found between CsO2
and OER (r=-0.44 p<0.001). Linear regression analysis showed that in
patients with Hb<90g/L the relationship was closer r2= 0.45, p<0.001 and in
patients with Hb<90g/L and Lac >2mM the relationship was r2=0.77,
p<0.001 (Figure 1). 
Figure 1. Relationship between CsO2 and OER at Hb <90 h/L and Lac >2.37 mM
(r2=0.77, p<0.001).
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The noninvasive NIRS measured CsO2 can be used as a surrogate
marker of oxygen extraction. Non invasive oximetry is a reproducible
method and demonstrates that as the critical region of anaerobic
metabolism begins with Hb falling and lactate rising the relationship
between CsO2 and OER is closer. This suggests a use for CsO2 in providing
critical information in the development of a transfusion trigger. 
References
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Thomas the Tank Engine significantly
improves the understanding of oxygen
delivery and hypoxaemia
JF Cosgrove*, ID Nesbitt*, DJ Kennedy†, M Sawdon‡, K Fordy§, P Laws*, J
Green*. *Perioperative and Critical Care, Newcastle upon Tyne Hospitals
NHS Trust, Newcastle upon Tyne, UK, †Faculty of Medical Sciences,
Newcastle University, Newcastle upon Tyne, UK, ‡School of Medicine and
Health, University of Durham, Stockton-on-Tees, UK, §Perioperative and
Critical Care, Sunderland Royal Hospitals, Sunderland, UK
Despite adequate background knowledge many physiological concepts are
poorly understood; students “know” but do not “understand”.1 Analogous
imagery can enhance understanding and Thomas the Tank Engine has been
used previously to demonstrate hypoxaemia.2-5 Such imagery has not been
evaluated in medical student education.
The aim of the study was to assess the effectiveness of Thomas the Tank
Engine in improving the understanding of hypoxaemia in Year One Medical
Students at the Universities of Newcastle and Durham. Two 
30-minute lectures on the subject were delivered to students. The control
lecture was a conventional presentation; the study lecture contained
additional images of Thomas the Tank Engine.4,5 Local Research Ethics
approval was advised as being unnecessary; HiT Entertainment-UK granted
permission for the use of the imagery of Thomas the Tank Engine.
Students were randomised into four groups (A-D.) A and B received the
control lecture, C and D the study lecture. All students undertook a 
20-question post-lecture multiple choice questionnaire (MCQ) on oxygen
delivery and hypoxaemia; A and C sat a similar pre-lecture MCQ as an
“evaluative preparatory drill” assessing background knowledge and
monitoring for priming.6,7 Pre and post-lecture MCQ scores for 
groups A and C were compared to assess for lecture effectiveness (A vs A
and C vs C) and for differences between the control and study lecture (pre-
MCQ A vs. pre-MCQ C and post-MCQ A vs post-MCQ C.) The effect of
priming was assessed by comparing post-lecture MCQ scores (A vs B and 
C vs D.)
Students also completed a post-lecture qualitative evaluation of eight
aspects of lecture quality: organisation, relevance, lecture “pitched” at an
appropriate level, difficulty, comprehension of oxygen delivery, assistance of
visual aids, interest, worthwhile. They were scored 1 to 5: strongly agree/
agree/ undecided/ disagree/ strongly disagree. All scores were collected
using an ARS-KEEpad system and compared using the Mann-Whitney 
U-test for non-parametric data. A p value <0.05 was regarded as significant.
Group numbers were A n=73, B n=56, C n=59, D n=53. Both lectures
significantly improved post-lecture MCQ scores (p<0.001.) Group A had a
significantly higher pre-lecture MCQ score compared to group C (median
16 vs 12, p<0.001); there was no difference post-lecture between A and C
(median 18 vs 17, p=0.4). Post-lecture MCQ scores were no different
between A and B (median 18 vs 18, p=0.14) or C and D (median 17 vs 17,
p=0.6.) With respect to qualitative evaluation the imagery also made the
lecture significantly more organised (p=0.006), interesting and stimulating
(p<0.001) and improved qualitative understanding (p<0.001.)
Images of Thomas the Tank Engine can significantly improve the
understanding of oxygen delivery and hypoxaemia in Year One Medical
Students. A pre-lecture MCQ did not create a priming effect in either group.
Acknowledgements: Professor M Mythen, Portex Professor of
Anaesthesia, University College London Hospitals and Dr R Armstrong,
Consultant in Anaesthesia and Intensive Care (Retired), University College
London Hospitals.
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Acute respiratory distress syndrome
(ARDS): outcomes in a tertiary referral
intensive care unit (ICU)
RH Johns, KAE Elliott, A Karim, S Boluda, C Matejowsky, GJ Bellingan,
DCJ Howell. Dept of Critical Care, University College Hospital, London, UK
ARDS is a severe life-threatening respiratory condition. A recent large meta-
analysis, which included patients with acute lung injury (ALI) as well as
ARDS, reported an ICU mortality of rate 44.3%.1 Reported ICU and
hospital mortality rates for ARDS alone are 53% and 61% in Scotland;2 and
49% and 58% in Europe.3 Our ICU manages a unique and complex cohort
of ARDS patients who often have high APACHE scores at admission. In this
study we examined outcomes in our ARDS patients and compared results
to published literature.  
All patients admitted to the ICU between May 2008 and Jan 2009
were included (n=1402). Patients meeting ARDS defining criteria were
identified prospectively and further data from our ICU CIMS (clinical
information management system) was assessed retrospectively by two
independent observers. ARDS was defined by ERS/ATS Consensus criteria
and absence of echocardiographic or clinical evidence of significant left
ventricular impairment or pulmonary oedema. In ARDS patients, the level
of compliance with low tidal volume (vt) ventilation, achievement of peak
airway pressures (PAP) of <30 cm H2O and neutral/negative fluid balance
(FB) strategies, during admission, was assessed.  
Of 1402 admissions (665 non-elective (ne), 737 elective (e)) ARDS
occurred in 67 patients (63 ne; 4 e). Overall incidence was 4.8%, and
9.5% amongst non-elective admissions (63/665). Mean (± standard error
of the mean) values were: Age 57 ± 2 years, APACHE II 27 ± 1, 
ICU length of stay 19 ± 3 days, duration of mechanical ventilation 
14 ± 2 days, ICU mortality 48%, and hospital mortality 55%. Overall
compliance with low vt ventilation was 84%, PAP <30 cm H2O: 71% and
neutral/negative FB: 62%. In survivors, compliance was 83%, 86% and
83% respectively.
Pneumonia and sepsis were the commonest precipitants of ARDS. Our
incidence is lower than the 8.1% reported in Scotland,2 which most likely
reflects the high number of elective surgical patients admitted to our unit.
Our admission APACHE II scores are higher than reported in this study
consistent with greater severity of illness in our ARDS patients. Despite
this, our mortality rates are lower than other published studies2-4 which
may be explained by our good adherence to current evidence-based
ventilatory and supportive strategies, as recommended by published
ARDSNet studies.
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Cognitive dysfunction following abdominal
aortic surgery: a pilot study
T Kelley, MS Thorniley, V Sekar, CN McCollum. Department of Academic
Surgery, University Hospital of South Manchester, Manchester, UK
Cognitive dysfunction is a frequent problem following major surgery.
However, not much is known about the role of cerebral haemodynamics on
postoperative cognitive function.
We recruited eight consecutive patients (mean age 70.2 years [63-90
years]) with an initial mini mental state exam (MMSE) †23 undergoing
elective abdominal aortic surgery were recruited. Cognitive testing using
CANTAB Eclipse (computerised test battery) was performed preoperatively
and at five and 14 days postoperatively. The middle cerebral arteries (MCA)
were insonated using a 2 MHz pulsed transcranial Doppler (TCD) probe.
The flow velocities, pulsatility and resistance indicies were monitored
continuously at all times.  
Four out of eight patients (50%) had cognitive impairment at five days
(20% drop in 20% of the tests), with a return to pre-op levels at 14 days in
seven out of eight patients (88%). Total duration of the procedure and
increased clamp times strongly predicted impaired reaction time at five days
(p=0.01 and p<0.01 respectively). The mean difference in spatial working
memory within errors test from pre-op to five days was 3.0, (p=0.5).
However, it strongly correlated with the greatest change in MCA flow
velocities following aortic clamping (p=0.037). The other test scores
assessing spatial working memory (total errors, between errors and mean
time to last response) just failed to achieve significance (p=0.08, p=0.09
and p=0.09 respectively).
The duration of operation and clamping are associated with
postoperative cognitive dysfunction (POCD) in patients undergoing
abdominal aortic surgery. Intraoperative changes in blood flow velocities
may contribute to the development of POCD. The relevance of these
findings to everyday life after abdominal aortic surgery needs to be studied
in greater detail.  
Do noise-cancelling headphones improve
sleep quality on the intensive care unit?
Hassall I, Latif I, McGrattan K, Pugh M. Critical Care Unit, Royal Preston
Hospital, Preston, Lancashire, UK
Patients do not sleep well on the intensive care unit (ICU), at least in part
due to the noisy environment.1 Poor sleep quality is associated with
immune system dysfunction, cardiovascular instability, depression and
delirium.2 Delirium alone is associated with an increase in ICU and hospital
stay and an increase in mortality.3
Noise-cancelling headphones are designed to minimise background
noise. We hypothesised that the wearing of these headphones may improve
the sleep quality of ICU patients.
Extubated patients following elective gynaecological or general surgery
admitted to the ICU post operatively were randomised to wearing noise-
cancelling headphones (Audio-Technica, Quiet point, ATH-ANC7) or not
for the first two postoperative nights. After each night patients completed
the Richards-Campbell Sleep Questionnaire (RCSQ).4 This consists of five
visual analogue scales covering the sleep domains of depth, latency,
awakenings, percentage time awake, and quality of sleep. The five scores
are averaged to produce a figure for overall sleep quality from 0-100mm
where 0 is good quality and 100 poor. We also collected information on
analgesics and sedatives prescribed to patients.
There were 11 patients in the treatment group and seven in the control
group. Five of the patients in the treatment group found the headphones
uncomfortable and were unable to wear them during the night. They did
not complete RCSQs. Of the remaining six in the treatment group three
patients stayed for two nights on the ICU. Of the seven in the control
group one stayed for two nights.
Visual analogue scores in the treatment group were consistently 
lower (better sleep quality) than in the control group. The average sleep
quality score derived from the RCSQ was 24.7mm in the treatment group
compared with 89.3mm in the control group.  
It is difficult to derive conclusions from this study since the numbers
are so small. Moreover, nearly half of the patients randomised to wearing
headphones found them too uncomfortable. In this small study patients
who were able to tolerate wearing headphones had a better quality of
sleep.  We intend to repeat this study to include larger numbers of
patients.
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Dose-dependent effects of dopexamine on
indices of shock and organ dysfunction in a
rodent model of laparotomy and
endotoxaemia
MN Bangash*, NS Patel*, CJ Hinds*, R Lever†, C Thiemermann*, RM
Pearse*. *Barts and The London School of Medicine and Dentistry, Queen
Mary’s University of London, UK, †School of Pharmacy, University of
London, UK
Sepsis related organ failure is associated with abnormal haemodynamics,
altered tissue microcirculation and oxygenation and an abnormal immune
response. Dopexamine is a synthetic catecholamine which may have
important clinical benefits but the effects of this agent on organ failure is
not fully understood. The objective of this study was to investigate the
effect of dopexamine on indices of organ failure in a rodent laparotomy and
endotoxaemia model.
Male Wistar rats (220-400 g) were allocated to one of five groups. All
procedures were performed in accordance with Home Office regulations.
Animals were anaesthetised with intra-peritoneal thiopental sodium
30 mg/kg following which tracheal, carotid artery and internal jugular
catheters were sited. A midline laparotomy was performed with small 
bowel exteriorisation in to a Saran wrap pouch. Sham group animals
underwent surgery and four hours of 4.3 mL/kg/h normal saline fluid
resuscitation with prior administration of endotoxin vehicle. Control group
animals received the same management and in addition received 
6 mg/kg E.Coli endotoxin over 10 minutes prior to fluid resuscitation.
Dopexamine groups received intra venous fluid, endotoxin and
dopexamine infusion at 0.5 µg/kg/min (Dopex 0.5 group), 1.0 µg/kg/min
(Dopex 1.0 group) or 2.0 µg/kg/min (Dopex 2.0 group). Blood samples
were taken for determination of lactate, base excess, leucocyte expression
of CD11b, urea, creatinine, alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST). At the end of the four hour protocol,
organ tissue was harvested to measure myeloperoxidase levels (marker of
leucocyte infiltration). 
Forty animals were studied. Groups were similar in all respects though
Dopex groups received 1.5 to 1.7 mL/kg more normal saline over the
course of the experiment compared to Controls. Endotoxin administration
was associated with a significant rise in plasma lactate, urea, creatinine,
AST and ALT. These changes appeared to be attenuated by dopexamine
infusion (Table). These effects were more marked in the Dopex 1.0 and
Dopex 2.0 groups. Leucocyte expression of CD11a integrin was decreased
in association with endotoxin administration while expression of CD11b
integrin was increased. Increasing doses of dopexamine were associated
with a non-significant decreasing trend in CD11b and CD11a. Tissue
myeloperoxidase levels are awaited but will be available for presentation at
the meeting. 
In a rodent model of laparotomy and endotoxaemia, abnormalities of
tissue perfusion and organ failure were less severe in animals receiving
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dopexamine infusion. This effect was more obvious at doses of
1.0 µg/kg/min and above. Further research is required to explore the effects
of dopexamine on leucocyte-endothelial adhesion and tissue micro-
vascular flow.
Funding acknowledgment: This research was supported by an Intensive
Care Society Young Investigator Award. RP holds an NIHR Clinician
Scientist Award.
Conflict of Interest: RP has received a grant from Circassia Holdings
Ltd. RP & CH are named inventors on a patent application relating to
dopexamine.
Effects of dopexamine on heart rate and parameters of shock and organ
dysfunction (*p<0.05 vs control group, **p<0.01 vs control group, Δ refers to
change from baseline to end).
Ascorbate improves endothelial function
and reduces systemic inflammation after
open aneurysm repair
MJ Duffy*‡, BA Mullan*, TR Craig*‡, DW Harkin†, DF McAuley*‡.
*Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern
Ireland, UK.  †Regional Vascular Unit, Royal Victoria Hospital, Belfast,
Northern Ireland, UK.  ‡Centre for Infection and Immunity, Queens
University of Belfast, Belfast, Northern Ireland, UK 
Open abdominal aortic aneurysm (AAA) repair is associated with the
systemic inflammatory response syndrome (SIRS) which may lead to organ
failure and death. This is mediated by ischaemia-reperfusion injury which
is associated with an increase in oxidative stress resulting in endothelial
dysfunction. In ischaemia-reperfusion injury there is a decrease in plasma
ascorbate, an aqueous phase antioxidant.
Our hypothesis was that intraoperative ascorbate administration could
reduce endothelial dysfunction associated with AAA repair.
A prospective double-blind randomised placebo-controlled clinical trial
was performed. Consecutive patients admitted for elective open AAA repair
were considered for recruitment. Ascorbate 2 g or placebo was given
intravenously prior to application of the aortic clamp.
Blood and urine samples were taken prior to and 4 hours after aortic
clamping. Microalbuminuria assessed by albumin:creatinine ratio(ACR)
was measured as a surrogate marker of systemic endothelial dysfunction.
Plasma levels of TNFα, IL-6 and IL-8 were measured by luminex 
bead array.
Concomitantly, bedside analysis of endothelial function was performed
using pulse wave analysis and calculation of the endothelial function index
(EFI) by measuring the response to endothelial dependent (salbutamol)
and independent (GTN) vasodilators.
Exhaled breath condensate(EBC) was collected prior to and after aortic
clamping and pH measured immediately as a marker of pulmonary
inflammation. Pulmonary function was measured by PF ratio. Patient
follow-up was until hospital discharge.
Thirty-one patients were studied, of which 13 received ascorbate and 18
placebo. There were no differences in demographics or clamp times
between groups. There was a significant rise in IL-6 in both treatment
(p=0.002) and placebo (p<0.001) groups. However, the 
post-operative level was lower in those who received ascorbate (p=0.03,
Figure 1).
EFI improved in the ascorbate group (p<0.001), whereas there was no
significant change in the placebo group (p=0.2, Figure 2). The ACR was
significantly increased with a similar rise encountered in both placebo and
treatment groups.
EBC pH fell after aortic clamping in both placebo (p=0.008) and
ascorbate (p=0.003) groups, but with no difference between groups. The PF
ratio also fell significantly in placebo (p=0.002) and ascorbate (p<0.001)
groups with no difference between groups. There were no differences in
duration of critical care or hospital stay. There was a single post-operative
fatality in the placebo group.
The intraoperative administration of parenteral ascorbate prevented the
increases in IL-6 encountered after aortic clamping. A bedside marker of
endothelial function was significantly improved by ascorbate
administration. Ascorbate may therefore play a role in modulating systemic
inflammation in open AAA repair. This study also highlights the ability of
aortic clamping to have an indirect effect on pulmonary inflammation as
evidenced by the fall in EBC pH. This important finding warrants further
investigation.
Cerebral oxygen saturation during
abdominal aortic surgery predicts
postoperative cognitive dysfunction
T Kelley, V Sekar, Z Bashir, CN McCollum, MS Thorniley.
Department of Academic Surgery, University Hospital of South Manchester,
Manchester, UK
Confusion and cognitive dysfunction are common following major vascular
surgery, but little is known about the causes. We studied the role of cerebral
oxygen saturation (CsO2) during surgery.
We recruited eight consecutive patients (mean age 70.2 years [63-90
years]) with an initial mini mental state exam (MMSE) †23 undergoing
elective abdominal aortic surgery were recruited. Cerebral oximetry was
studied preoperatively, intraoperatively (from surgical incision to the end of
surgery), and at five and 14 days postoperatively. Cognitive testing using
CANTAB Eclipse (computerised test battery) was performed preoperatively
and at Five and 14 days postoperatively.  
Four out of eight patients (50%) had cognitive impairment at five days
(>20% fall in at least 20% of the tests), with a return to preop levels at 14
days in seven of the patients (88%). The maximum percentage fall in CsO2
during surgery correlated significantly with a worsening reaction time at
five days (p=0.031). The oxygen extraction ratio at declamp also correlated
significantly with the reaction times at five days (p=0.035).  
Abdominal aortic surgery is associated with cognitive impairment five
days later which recovered to pre-op levels at 14 days. Changes in cerebral
oxygen saturations during surgery may explain confusion and cognitive
dysfunction following major surgery,
Sham Control Dopex 0.5 Dopex 1.0 Dopex 2.0
(n=8) (n=7) (n=8) (n=8) (n=9)
IV fluid (mL/kg) 21.7 (0.6) 21.1 (0.6) 22.6 (0.9)* 22.6 (0.4)* 22.8 (1.4)**
Heart rate (bpm) 415 (18) 453 (42) 506 (41)** 487 (16) 483 (13)
Δ Base excess 0.7 (3.8)** -7.3 (4.6) -5.9 (3.2) -3.5 (2.4) -1.8 (3.5)*
(mmol/L)
Δ Lactate (mmol/L) 0.6 (1.0)* 3.1 (2.2) 2.0 (1.4) 0.4 (1.1)** 0.5 (1.6)**
Urea (mmol/L) 8.4 (2.9)** 17.1 (4.6) 15.1 (1.7) 14.7 (1.8) 12.7 (2.9)*
Creatinine ( mol/L) 36 (6)** 86 (26) 54 (14)* 40 (18)** 52 (24)**
ALT (IU/L) 56 (18)** 162 (90) 88 (15)** 79 (19)** 77 (22)**
AST (IU/L) 187 (94)** 472 (235) 349 (69) 275 (88)* 289 (90)*
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Defective efferocytosis due to aberrant
intra-pulmonary steroid metabolism
contributes to persistent inflammation in
ARDS
CR Bassford*, S McKeown‡, C OKane‡, F Gao*§, DF McAuley‡, GD
Perkins*§, D Thickett†. *Academic Department of Critical Care,
Anaesthesia and Pain, Heart of England NHS Foundation Trust,
Birmingham, UK, †Lung Inflammation Investigation Unit, University of
Birmingham, Birmingham, UK, ‡Respiratory Medicine Research
Programme, Queen’s University, Belfast, UK, §Warwick Medical School
Clinical Trials Unit, University of Warwick, Coventry, UK
Efferocytosis is the removal of spent and apoptotic cells, and is necessary
for the resolution of inflammation. Failure of efferocytosis results in pro-
inflammatory mediator release and further tissue damage.1 In the acute
respiratory distress syndrome (ARDS) a defect in the removal of spent
neutrophils by alveolar macrophages (AM) may contribute to persistent
inflammation. Corticosteroids increase efferocytosis in many types of
phagosome; and we have previously demonstrated a decrease in cortisol
levels in the broncho alveolar lavage fluid (BALF) of patients with
persistently severe ARDS.2 We therefore hypothesised that efferocytosis in
ARDS was influenced by the availability of active glucocorticoids within the
lung, and the intra-pulmonary metabolism of corticosteroids by
hydroxysteroid dehydrogenase (HSD).
An efferocytosis assay using fluorescently labelled apoptotic neutrophils
was used in conjunction with established HSD activity assays and flow
cytometric techniques.
Efferocytosis was decreased by BALF taken from patients at onset of
ARDS, compared to controls (p=0.01). Efferocytosis induced by BALF
taken at day 4 of ARDS was higher than that of day 0 BALF (p=0.008), but
no different from that of control (p=0.067). BALF had no effect on cell
viability. Efferocytosis is up-regulated by cortisol and cortisone compared
to controls (mean efferocytosis index: control=0.05, cortisone=0.09,
cortisol=0.11; n=9, p=0.001). Efferocytosis up-regulation by cortisone is
suppressed by HSD inhibitors (n=7, p=0.037). Salbutamol also up-regulates
efferocytosis in a dose dependent manner (ANOVA: p=0.001), and has an
additional effect when combined with cortisol. Alveolar macrophages from
ARDS patients have decreased HSD conversion of cortisone to cortisol at
diagnosis of ARDS compared to day 4 (0.10 vs 0.57 pmol/million cells/hr,
p=0.039, n=12). Annexin V/PI flow cytometry of ARDS BALF neutrophils
(n=14) demonstrates an increase in late apoptotic and necrotic cells
compared to human LPS challenge (n=20).
Local steroid metabolism by HSD is dysregulated early in ARDS. Low
cortisol levels and defective HSD activity is associated in-vitro with
defective efferocytosis. ARDS BALF suppresses efferocytosis of apoptotic
neutrophils suggesting that the alveolar phagosome may be defective in
ARDS. This hypothesis is supported by flow cytometry data suggesting that
these changes may contribute to persistence of inflammation in ARDS.
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Intensive care outcomes and quality of life
in lung transplant patients requiring
intensive care admission 
R Shetty*, P Nair†, AR Glanville†. *Intensive Care Unit, UCL Hospital,
London, UK, †Intensive Care Unit and Lung Transplantation, St Vincent’s
Hospital, Sydney, Australia
ICU admission is common in lung transplant recipients.1 The reported
mortality is around 37%.2 Clinicians face a difficult challenge determining
which patients would benefit from being admitted to ICU. Unfortunately,
little is known about the quality of life of patients who survive after
admission to ICU. In this study, our aim was to gain a better understanding
of this aspect.
All patients who underwent Single/Bilateral or Heart-Lung transplant
from 2000 to 2006 were included in the study. Demographic data and
details of ICU admissions were collected. Patients were requested to
complete the SF36v2 questionnaire to assess quality of life. Sixty-six of 183
patients required one or more admissions to ICU from the time of their
lung transplant until Dec 2007 when the data was collected (Study Group).
ICU admissions in the immediate post-op period were excluded. Sixty-six
patients were randomly selected from the remaining 117 patients to form
the Control Group. Eleven patients (16.7%) in each group died prior to
study commencement. Overall response rate to the questionnaire was 73%. 
Commonest indications for lung transplant included cystic fibrosis and
emphysema. The number of transplants performed each year over the study
period was found to increase. Fewer patients whose transplant operation
occurred in the recent years were admitted to ICU. Despite this the annual
admissions to ICU have increased over the years indicating increased
transplant load. The major indications for ICU admission (76%) were graft
related problems – 55% of patients were admitted within one year of their
transplant surgery. The mean length of ICU stay was 4.5 days (range 1-32
days). Twenty-four patients (38%) required mechanical ventilation (MV).
Mean duration of MV was 3.8 days (range 1-19 days). There were no
deaths in ICU. There was no statistically significant difference in quality of
life scores, either in the physical (42.67 vs 45.32, p= 0.322) or the mental
health domains between the study group and the control group (45.09 vs
47.79, p= 0.381). Furthermore, encouragingly, these scores were not
significantly different from the Australian Norms for quality of life in a
general population.
We can conclude from our study that both in terms of ICU outcomes as
well as long-term quality of life in lung transplant patients who required
admission to ICU, the risk-benefit ratio appears favourable. Despite its
limitations, this is the only study, which looks in to quality of life in this
patient group, and has the highest number of patients compared to other
studies. Prospective, matched multi-centre studies would help to confirm
our findings.
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A retrospective study estimating the
prevalence of human immunodeficiency
virus amongst critically ill patients in a
London teaching hospital 
D Bruce-Hickman*, SR Strachan†. *University College London Medical
School, King’s College Hospital, London, UK, †Intensive Care Units, King’s
College Hospital, London, UK
The estimated prevalence of human immunodeficiency virus (HIV) in the
UK is 0.127% with a regional variation between 0.025% and 1.192%; King’s
College Hospital is situated within a high prevalence area. The prevalence
of HIV in critical care is unknown and with over a quarter of HIV-positive
people unaware of their serostatus the Health Protection Agency (HPA) has
called for increased testing.1 This retrospective study was undertaken in
order to measure the prevalence of HIV in our ICU from clinically-directed
testing and compare it with the estimated prevalence from the population
we serve, calculated from HPA data.  
HIV testing in critical care is problematic due to the current
requirement for consent;2 therefore we also noted the proportion of patients
tested who had capacity to consent. Furthermore, we looked for
demographic or clinical indicators to enable critical care clinicians to more
appropriately direct HIV testing in the absence of ability to consent.  
We calculated the HIV prevalence for all ICU admissions from
01/04/2008 to 31/03/2009 by Primary Care Trust (PCT) HPA data to be
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0.59%. HIV tests were performed on 20 of 1589 ICU patients during the
year studied, by including a further 14 known HIV-positive patients our
overall testing rate was 2.14%; we measured the HIV prevalence from this
clinically-directed testing to be 1.13%. These results are statistically
different (p=0.008) suggesting patients with HIV are more likely to require
critical care compared with the general population.
If there is no hidden cohort, 78% (14/18) of HIV-positive patients had
their status known on ICU admission. Forty-five percent (9/20) of the
patients tested for HIV following ICU admission had capacity to consent at
time of testing, 30% (6/20) lacked capacity and for 25% (5/20) capacity was
unknown. There were no real clinical indicators of serostatus and no patient
tested had more than one risk factor for HIV known when tested. The only
indicators of increased HIV risk were demographic, with seropositive
patients originating from either a high prevalence country or PCT.  
The HIV prevalence in our ICU measured from clinically-directed
testing was found to be nearly twice that estimated from HPA population
data. The UK National Guidelines for HIV testing3 recommend testing
where the diagnosed HIV prevalence in the local population exceeds 0.2%
so it could be argued that in our hospital testing should be routine. The
true prevalence of HIV in critical care will only be known by testing all ICU
admissions and this study provides the information required to calculate
the sample size needed for a prospective study to ascertain a more robust
prevalence of HIV in our ICU by anonymous testing of all admissions. By
comparing the true prevalence with the clinically-directed prevalence
measured from this study we shall then be able to determine whether there
are additional seropositive critically ill patients and be able to allocate
appropriate resources for this cohort of patients. The prospective study will
also examine the acceptability of routine HIV testing within the critical care
community.  
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Sequential gene expression profiles
following cardiac surgery involving
cardiopulmonary bypass
E Svoren*, J Radhakhrishnan†, P Ellis‡, C Langford‡, JC Knight†, CJ
Hinds*. *Queen Mary University of London, Barts and The London School
of Medicine and Dentistry, UK,  †Wellcome Trust Centre for Human
Genetics, Oxford, UK,  ‡Wellcome Trust Sanger Institute, Cambridge, UK
Differential expression of specific genes has been associated with
postoperative brain injury and individual variation in the severity of the
host response following cardiac surgery.1,2 The aim of this study was to
document sequential changes in global gene expression and provide a
genome wide description of the evolution of gene expression during the
host response to low risk, elective cardiac surgery.
Having obtained ethics committee approval and informed consent, 15
Caucasian patients scheduled for elective cardiac surgery involving
cardiopulmonary bypass (CPB) were recruited (10 coronary artery bypass
graft, three valve replacements and three combined procedures, age 65 ±11
years, 12 male). Postoperative recovery was uneventful with only minor
complications. All patients were alive 28 days after surgery. Peripheral
blood leukocytes were isolated before induction of anaesthesia, after
admission to intensive care and 24 hours after surgery, using the
LeukoLOCK system (Ambion). Total RNA was isolated and genome-wide
gene expression profiles obtained using the Illumina Human WG-6 v3
array that interrogates over 48,000 unique transcripts.
Gene expression profiles were homogeneous across all patients.
Principal components analysis confirmed that the timing of the sample
collection with respect to surgery was the primary determinant of changes
in gene expression. Multiple genes involved in the innate immune response
were found to be differentially regulated following cardiac surgery by fitting
a linear model using the R package “limma”. In the immediate
postoperative period genes encoding Toll-like receptors TLR2, TLR4 and
TLR6 were significantly up-regulated. NFKB1 was unchanged in the
immediate post operative period but was up-regulated on the first post-
operative day. In the acute phase response pathway IL1β was up-regulated
in both postoperative samples. The transcription factors STAT3 and CEBPB
were also up regulated, while STAT4 and IFNγ were down-regulated.
Pathways analysis was performed for each comparison using the gene-set
enrichment algorithm. The significance of the enriched pathways was
evaluated by a permutation algorithm involving phenotype switching.
Pathways enriched in the postoperative period (p<0.05) included those
related to the acute inflammatory response (IL-18, IL-6, IL-1β, IL8, IL10),
signalling (MYD88, MYH9), apoptosis (AKT-1), myeloid differentiation
(BCL6, TIMP1), coagulation (CD-36, GNA-13), complement (C1QA, 
CR-1), carbohydrate metabolism (LDHA, G6PD), lipid catabolic processes
(PLCB2) and fluid transport (AQP9). In general similar pathways were
enriched at both time-points but the pattern of gene enrichment changed
over time.
These data provide novel insights into the evolution of the host
response to surgical and inflammatory insults. This pilot data will inform
further studies in which we will investigate the influence of DNA sequence
variation on changes in gene expression during the systemic inflammatory
response and will provide a model of sterile systemic inflammation for
comparison with sepsis survivors and non-survivors.
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Hand position for external chest
compressions — centre of the chest or the
inter-nipple line? 
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Effective cardio-pulmonary resuscitation is a key link in the chain of
survival.1 There remains uncertainty over the optimal method for
identifying the position on the chest where hands should be placed in order
to perform external chest compression. There is little scientific evidence
regarding the optimum hand position for chest compressions and currently
the International Liaison Committee on Resuscitation (ILCOR) has
concluded that there is ‘insufficient evidence for and against a specific hand
position for chest compressions during CPR in adults’.2 The paucity of
evidence supporting one method over another has led disparity between
international guidelines with the American Heart Association (AHA)
advocating that the rescuer should compress ‘the lower half of the victim’s
sternum in the middle of the chest between the nipples’, referred to as the
inter-nipple line, whereas the European Resuscitation Council (ERC)
guidelines taught Basic Life Support (BLS)  providers to ‘place the heel of
one hand in the centre of the victim’s chest’ for chest compressions.2,3 
The aim of this study is to identify and compare BLS providers’ assess-
ment of the ‘inter-nipple line’ (INL) and ‘centre of the chest’ (CoC), and the
relationship between these positions and underlying anatomical structures.   
Following approval from research ethics committee, 30 patients (22
males, mean age  60.5±15.0 and eight females average age 50.0 ± 14.8)
having elective CT scans of the thorax at Birmingham Heartlands Hospital
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between February and May 2009 were recruited. Two photos were taken,
one photo with anatomical markers for the sternum and one without
markers. Copies of unmarked photographs were distributed to 30
healthcare students trained in BLS who marked the CoC and INL for each
patient. Mean values of CoC and INL were calculated and underlying
structures identified from CT scans.  Additional questions explored BLS
providers’ preference of hand positions.
CoC was identified at 0.69 (CI 0.63-0.75) of total length of sternum
measured from the sternal notch compared to INL at 0.78 (CI 0.75-0.82)
(p<0.001). Sixty percent INL and 46% CoC fell on ascending aorta, 3.3% of
hand positions using the INL approach were inferior to the ventricles. The
majority (80%) of BLS providers would not expose the chest before starting
chest compressions whilst 60% preferred the CoC approach.
BLS providers’ perception of the INL was significantly lower than the
CoC with increased risk of causing harm to patients. The CoC technique
for hand placement for chest compressions was preferred.
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